Dermal Filler - Medical Devices Pipeline Assessment, 2018

Dermal Filler - Medical Devices Pipeline Assessment, 2018


  • Products Id :- GDME0700EPD
  • |
  • Pages: 129
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Dermal Filler-Medical Devices Pipeline Assessment, 2018

Summary

GlobalData's Medical Devices sector report, Dermal Filler-Medical Devices Pipeline Assessment, 2018" provides an overview of Dermal Filler currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Dermal Filler pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Dermal Filler under development

- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities

- The report reviews the major players involved in the development of Dermal Filler and list all their pipeline projects

- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage

- The report provides key clinical trial data of ongoing trials specific to pipeline products

- Recent developments in the segment / industry.

Reasons to buy

The report enables you to-

- Formulate significant competitor information, analysis, and insights to improve R&D strategies

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Identify and understand important and diverse types of Dermal Filler under development

- Develop market-entry and market expansion strategies

- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline

- In-depth analysis of the product's current stage of development, territory and estimated launch date.



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

1 Table of Contents

1 Table of Contents 2

1.1 List of Tables 4

1.2 List of Figures 6

2 Introduction 7

2.1 Dermal Filler Overview 7

3 Products under Development 8

3.1 Dermal Filler-Pipeline Products by Stage of Development 8

3.2 Dermal Filler-Pipeline Products by Territory 9

3.3 Dermal Filler-Pipeline Products by Regulatory Path 11

3.4 Dermal Filler-Pipeline Products by Estimated Approval Date 13

4 Dermal Filler-Pipeline Products under Development by Companies 14

4.1 Dermal Filler Companies-Pipeline Products by Stage of Development 14

4.2 Dermal Filler-Pipeline Products by Stage of Development 16

5 Dermal Filler Companies and Product Overview 18

5.1 Aeon Astron Corporation Company Overview 18

5.2 Allergan Inc Company Overview 19

5.3 Allergan Plc Company Overview 21

5.4 Almirall Ltd Company Overview 23

5.5 Anika Therapeutics Inc Company Overview 24

5.6 Bioxis Pharmaceuticals Company Overview 25

5.7 Celltrix AB Company Overview 29

5.8 CollPlant Ltd Company Overview 30

5.9 Dermele Skin Care, LLC Company Overview 31

5.10 EternoGen Aesthetics LLC Company Overview 32

5.11 Genzyme Corp Company Overview 33

5.12 Innovia LLC Company Overview 34

5.13 Juvenis Ltd Company Overview 35

5.14 Khorionyx SA Company Overview 36

5.15 Moma Therapeutics, Inc. Company Overview 37

5.16 N8 Medical Inc Company Overview 38

5.17 Oligo Medic Inc Company Overview 39

5.18 PetVivo Holdings Inc Company Overview 40

5.19 Regenscientific Company Overview 42

5.20 Samyang Biopharmaceuticals Corp Company Overview 43

5.21 Sekisui Medical Co Ltd Company Overview 44

5.22 Shanghai Haohai Biological Technology Co Ltd Company Overview 45

5.23 Shin Poong PharmCo Ltd Company Overview 47

5.24 Sinclair Pharma PLC Company Overview 48

5.25 Sofregen Medical Inc Company Overview 54

5.26 TEI Biosciences Inc Company Overview 55

5.27 University of California Santa Barbara Company Overview 56

6 Dermal Filler- Recent Developments 57

6.1 Jul 05, 2018: Sinclair Pharma: Trading Update for the 6 months to 30 June 2018 57

6.2 Jun 04, 2018: SWAG Penis Enhancement Procedure Developed by Top Plastic Surgeon Achieving Optimal Results 58

6.3 May 21, 2018: Nestle Skin Health Announces the FDA Approval of Restylane Lyft for Hands, the First and Only Hyaluronic Acid (HA) Dermal Filler for Use in the Back of Hands 59

6.4 May 15, 2018: BTG: Final Results For year ended 31 March 2018 60

6.5 May 09, 2018: FibroGen Reports First Quarter 2018 Financial Results 66

6.6 May 08, 2018: Smith & Nephew: Change of Directorate 68

6.7 May 08, 2018: CollPlant Files U.S. Patent Application for Next Generation Dermal Filler 68

6.8 May 03, 2018: Smith & Nephew First Quarter 2018 Trading Report 68

6.9 May 02, 2018: Anika Reports First Quarter 2018 Financial Results 71

6.10 Apr 30, 2018: Sinclair Pharma: Preliminary results for 12 months ended 31 December 2017 72

6.11 Apr 30, 2018: Sinclair secures EUR23 million debt facility 75

6.12 Apr 09, 2018: Merz Aesthetics Launches New Belotero Lips Dermal Filler Products 76

6.13 Apr 04, 2018: Namal Nawana appointed Chief Executive Officer of Smith & Nephew 77

6.14 Mar 20, 2018: Governor Abbott Announces Smith & Nephew Adding New Jobs In Fort Worth 78

6.15 Mar 05, 2018: Anika Therapeutics Names Joseph Darling As CEO And Director 79

6.16 Mar 01, 2018: Smith & Nephew: Change in Directorate 80

6.17 Feb 27, 2018: FibroGen Announces Fourth Quarter and Full Year 2017 Financial Results 80

6.18 Feb 21, 2018: Anika Announces Fourth Quarter and Full Year 2017 Financial Results 81

6.19 Feb 16, 2018: Merz North America to Highlight Treatments at American Academy of Dermatology Annual Meeting 82

6.20 Feb 08, 2018: Smith & Nephew Fourth Quarter Trading and Full Year 2017 Results 83

6.21 Jan 31, 2018: Smith & Nephew Appoints Roland Diggelmann As Non-Executive Director 84

6.22 Jan 31, 2018: Appointment of Roland Diggelmann as Non-Executive Director 85

6.23 Jan 16, 2018: Galderma Introduces Restylane Skinboosters 85

6.24 Jan 16, 2018: Sinclair Pharma: Ellanse Approved for Brazil 86

7 Appendix 125

7.1 Methodology 125

7.2 About GlobalData 128

7.3 Contact Us 128

7.4 Disclaimer 128

1.2 List of Figures

Figure 1: Dermal Filler-Pipeline Products by Stage of Development 9

Figure 2: Dermal Filler-Pipeline Products by Territory 10

Figure 3: Dermal Filler-Pipeline Products by Regulatory Path 12

Figure 4: Dermal Filler-Pipeline Products by Estimated Approval Date 14

1.1 List of Tables

Table 1: Dermal Filler-Pipeline Products by Stage of Development 9

Table 2: Dermal Filler-Pipeline Products by Territory 10

Table 3: Dermal Filler-Pipeline Products by Regulatory Path 12

Table 4: Dermal Filler-Pipeline Products by Estimated Approval Date 14

Table 5: Dermal Filler Companies-Pipeline Products by Stage of Development 15

Table 6: Dermal Filler-Pipeline Products by Stage of Development 17

Table 7: Aeon Astron Corporation Pipeline Products & Ongoing Clinical Trials Overview 19

Table 8: BioDermal Filler-Product Status 19

Table 9: BioDermal Filler-Product Description 19

Table 10: Allergan Inc Pipeline Products & Ongoing Clinical Trials Overview 20

Table 11: JUVEDERM Volbella-Product Status 20

Table 12: JUVEDERM Volbella-Product Description 20

Table 13: VYC-25L Hyaluronic Acid Injectable Gel-Product Status 21

Table 14: VYC-25L Hyaluronic Acid Injectable Gel-Product Description 21

Table 15: Allergan Plc Pipeline Products & Ongoing Clinical Trials Overview 22

Table 16: HA Threads-Product Status 22

Table 17: HA Threads-Product Description 22

Table 18: Juvederm Volift-Nasolabial Folds-Product Status 23

Table 19: Juvederm Volift-Nasolabial Folds-Product Description 23

Table 20: Almirall Ltd Pipeline Products & Ongoing Clinical Trials Overview 24

Table 21: Hyaluronic Acid Facial Filler-Product Status 24

Table 22: Hyaluronic Acid Facial Filler-Product Description 24

Table 23: Anika Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 25

Table 24: Next Generation ELEVESS Dermal Filler-Product Status 25

Table 25: Next Generation ELEVESS Dermal Filler-Product Description 25

Table 26: Bioxis Pharmaceuticals Pipeline Products & Ongoing Clinical Trials Overview 26

Table 27: CYTOSIAL Deep Wrinkle-Product Status 26

Table 28: CYTOSIAL Deep Wrinkle-Product Description 26

Table 29: CYTOSIAL Medium-Product Status 27

Table 30: CYTOSIAL Medium-Product Description 27

Table 31: Cytosial Volume-Product Status 27

Table 32: Cytosial Volume-Product Description 27

Table 33: Cytosmile-Product Status 28

Table 34: Cytosmile-Product Description 28

Table 35: MTI-12-Aesthetic Device-Product Status 28

Table 36: MTI-12-Aesthetic Device-Product Description 29

Table 37: MTI-12-Surgical Repair-Product Status 29

Table 38: MTI-12-Surgical Repair-Product Description 29

Table 39: Celltrix AB Pipeline Products & Ongoing Clinical Trials Overview 30

Table 40: Credurance-Product Status 30

Table 41: Credurance-Product Description 30

Table 42: CollPlant Ltd Pipeline Products & Ongoing Clinical Trials Overview 31

Table 43: Next Generation Dermal Filler-Product Status 31

Table 44: Next Generation Dermal Filler-Product Description 31

Table 45: Dermele Skin Care, LLC Pipeline Products & Ongoing Clinical Trials Overview 32

Table 46: Gold Nanoparticle Dermal Filler-Product Status 32

Table 47: Gold Nanoparticle Dermal Filler-Product Description 32

Table 48: EternoGen Aesthetics LLC Pipeline Products & Ongoing Clinical Trials Overview 33

Table 49: Cellifique-Product Status 33

Table 50: Cellifique-Product Description 33

Table 51: Genzyme Corp Pipeline Products & Ongoing Clinical Trials Overview 34

Table 52: Dermal Gel Extra-Product Status 34

Table 53: Dermal Gel Extra-Product Description 34

Table 54: Innovia LLC Pipeline Products & Ongoing Clinical Trials Overview 35

Table 55: Wrinkle Filler-Product Status 35

Table 56: Wrinkle Filler-Product Description 35

Table 57: Juvenis Ltd Pipeline Products & Ongoing Clinical Trials Overview 36

Table 58: Tenergel-Product Status 36

Table 59: Tenergel-Product Description 36

Table 60: Khorionyx SA Pipeline Products & Ongoing Clinical Trials Overview 37

Table 61: Autologous Globin Dermal Filler-Product Status 37

Table 62: Autologous Globin Dermal Filler-Product Description 37

Table 63: Moma Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 38

Table 64: Restogel-131-Product Status 38

Table 65: Restogel-131-Product Description 38

Table 66: N8 Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 39

Table 67: Ceragenin-Infused Dermal Filler-Product Status 39

Table 68: Ceragenin-Infused Dermal Filler-Product Description 39

Table 69: Oligo Medic Inc Pipeline Products & Ongoing Clinical Trials Overview 40

Table 70: AntaRep-Product Status 40

Table 71: AntaRep-Product Description 40

Table 72: PetVivo Holdings Inc Pipeline Products & Ongoing Clinical Trials Overview 41

Table 73: Dermal Filler-Product Status 41

Table 74: Dermal Filler-Product Description 41

Table 75: Dermal Filler-Lip-Product Status 42

Table 76: Dermal Filler-Lip-Product Description 42

Table 77: Regenscientific Pipeline Products & Ongoing Clinical Trials Overview 43

Table 78: Renu Soft Tissue Volumizing Filler-Aesthetic-Product Status 43

Table 79: Renu Soft Tissue Volumizing Filler-Aesthetic-Product Description 43

Table 80: Samyang Biopharmaceuticals Corp Pipeline Products & Ongoing Clinical Trials Overview 44

Table 81: Aesthetic Filler-Product Status 44

Table 82: Aesthetic Filler-Product Description 44

Table 83: Sekisui Medical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 45

Table 84: NADGL-Product Status 45

Table 85: NADGL-Product Description 45

Table 86: Shanghai Haohai Biological Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 46

Table 87: QST Gel-Product Status 46

Table 88: QST Gel-Product Description 46

Table 89: Third Generation Matrifill-Product Status 47

Table 90: Third Generation Matrifill-Product Description 47

Table 91: Shin Poong PharmCo Ltd Pipeline Products & Ongoing Clinical Trials Overview 48

Table 92: FreeWink-Product Status 48

Table 93: FreeWink-Product Description 48

Table 94: Sinclair Pharma PLC Pipeline Products & Ongoing Clinical Trials Overview 49

Table 95: Atlean-Product Status 49

Table 96: Atlean-Product Description 50

Table 97: Ellanse Lidocaine-Product Status 50

Table 98: Ellanse Lidocaine-Product Description 50

Table 99: Ellanse-E-Product Status 51

Table 100: Ellanse-E-Product Description 51

Table 101: Ellanse-L-Product Status 51

Table 102: Ellanse-L-Product Description 52

Table 103: Ellanse-M-Product Status 52

Table 104: Ellanse-M-Product Description 52

Table 105: Ellanse-S-Product Status 53

Table 106: Ellanse-S-Product Description 53

Table 107: Perfectha G-Product Status 53

Table 108: Perfectha G-Product Description 54

Table 109: Perfectha Lidocaine-Product Status 54

Table 110: Perfectha Lidocaine-Product Description 54

Table 111: Sofregen Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 55

Table 112: Silk Protein-Tissue/Dermal Filler-Product Status 55

Table 113: Silk Protein-Tissue/Dermal Filler-Product Description 55

Table 114: TEI Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview 56

Table 115: Injectable Dermal Filler-Product Status 56

Table 116: Injectable Dermal Filler-Product Description 56

Table 117: University of California Santa Barbara Pipeline Products & Ongoing Clinical Trials Overview 57

Table 118: Needle Free Injector-Product Status 57

Table 119: Needle Free Injector-Product Description 57

Table 120: Glossary 128

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com
 

Aeon Astron Corporation

Allergan Inc

Allergan Plc

Almirall Ltd

Anika Therapeutics Inc

Bioxis Pharmaceuticals

Celltrix AB

CollPlant Ltd

Dermele Skin Care, LLC

EternoGen Aesthetics LLC

Genzyme Corp

Innovia LLC

Juvenis Ltd

Khorionyx SA

Moma Therapeutics, Inc.

N8 Medical Inc

Oligo Medic Inc

PetVivo Holdings Inc

Regenscientific

Samyang Biopharmaceuticals Corp

Sekisui Medical Co Ltd

Shanghai Haohai Biological Technology Co Ltd

Shin Poong PharmCo Ltd

Sinclair Pharma PLC

Sofregen Medical Inc

TEI Biosciences Inc

University of California Santa Barbara

Aeon Astron Corporation, BioDermal Filler; Allergan Inc, JUVEDERM Volbella; Allergan Inc, VYC-25L Hyaluronic Acid Injectable Gel; Allergan Plc, HA Threads; Allergan Plc, Juvederm Volift - Nasolabial Folds; Almirall Ltd, Hyaluronic Acid Facial Filler; Anika Therapeutics Inc, Next Generation ELEVESS Dermal Filler; Bioxis Pharmaceuticals, CYTOSIAL Deep Wrinkle; Bioxis Pharmaceuticals, CYTOSIAL Medium; Bioxis Pharmaceuticals, Cytosial Volume; Bioxis Pharmaceuticals, Cytosmile; Bioxis Pharmaceuticals, MTI-12 - Aesthetic Device; Bioxis Pharmaceuticals, MTI-12 - Surgical Repair; Celltrix AB, Credurance; CollPlant Ltd, Next Generation Dermal Filler; Dermele Skin Care, LLC, Gold Nanoparticle Dermal Filler; EternoGen Aesthetics LLC, Cellifique; Genzyme Corp, Dermal Gel Extra; Innovia LLC, Wrinkle Filler; Juvenis Ltd, Tenergel; Khorionyx SA, Autologous Globin Dermal Filler; Moma Therapeutics, Inc., Restogel-131; N8 Medical Inc, Ceragenin-Infused Dermal Filler; Oligo Medic Inc, AntaRep; PetVivo Holdings Inc, Dermal Filler; PetVivo Holdings Inc, Dermal Filler - Lip; Regenscientific , Renu Soft Tissue Volumizing Filler - Aesthetic; Samyang Biopharmaceuticals Corp, Aesthetic Filler; Sekisui Medical Co Ltd, NADGL; Shanghai Haohai Biological Technology Co Ltd, QST Gel; Shanghai Haohai Biological Technology Co Ltd, Third Generation Matrifill; Shin Poong PharmCo Ltd, FreeWink; Sinclair Pharma PLC, Atlean; Sinclair Pharma PLC, Ellanse Lidocaine; Sinclair Pharma PLC, Ellanse-E; Sinclair Pharma PLC, Ellanse-L; Sinclair Pharma PLC, Ellanse-M; Sinclair Pharma PLC, Ellanse-S; Sinclair Pharma PLC, Perfectha G; Sinclair Pharma PLC, Perfectha Lidocaine; Sofregen Medical Inc, Silk Protein - Tissue/Dermal Filler; TEI Biosciences Inc, Injectable Dermal Filler; University of California Santa Barbara, Needle Free Injector

select a license
Single User License
USD 4000 INR 285520
Site License
USD 8000 INR 571040
Corporate User License
USD 12000 INR 856560

NEWSLETTER BY CATEGORY




Testimonials

I would like to thank Ken research team for meeting our report deliverables. The report is very good and we appreciate your well cooperation. ...

The research you conducted was very helpful for us and the integrity of your research approach gave us great confidence in the data. Look forward to collaborating again in future...

An excellent provider. Thorough, precise and outstanding insight. They drill down to what we need and their reports are effective at integrating text with supporting graphics and charts. Their reports are a great resource to go back too. ...

Coherent, high-quality, thoroughly-researched reports. We received a very quick response to all our queries which eventually expedited the entire process....

Well structured, the insights they shared with us were very helpful and reliable. Their timely assistance make their services invaluable to us. I would highly recommend them and would definitely use them again in the future if needed...



Ken Research Private Limited, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

sales [@] kenresearch.com